Brand names: Nabi-Hb
Human Immunoglobulin · Virus Neutralization
Route: Intramuscular
Contraindications
CONTRAINDICATIONS Individuals known to have had an anaphylactic or severe systemic reaction to human globulin should not receive Nabi-HB, Hepatitis B Immune Globulin (Human), or any other human immune globulin. Nabi-HB contains not more than 40 micrograms per mL IgA. Individuals who are deficient in IgA have the potential to develop antibodies against IgA and anaphylactic reactions. The physician must weigh the potential benefit of treatment with Nabi-HB against the potential for hypersensitivity reactions.
Pregnancy & Breastfeeding
Pregnancy Category C Animal reproduction studies have not been conducted with Nabi-HB. It is also not known whether Nabi-HB can cause fetal harm when administered to a pregnant woman or can affect a woman’s ability to conceive. Nabi-HB should be given to a pregnant woman only if clearly indicated.
1 interaction on record
Live virus vaccines should be deferred until approximately three months after administration of Hepatitis B Immune Globulin. Revaccination may be necessary if given shortly after live virus vaccination.
Source: NLP:hepatitis b immune globulin (human)